Try our Advanced Search for more refined results
Life Sciences - December, 2010
141 articles
- Defense Bar Is Big Winner In 2010 Securities Rulings
- Bilski Headlines Influential IP Rulings In 2010
- Skilling Set Pace For White Collar Rulings In 2010
- Whistleblowers Key To Big Pharma PL Deals In 2010
- Down Economy Fueled Employment Settlements In 2010
- Competition Cases To Watch In 2011
- Health Care Regulation To Watch In 2011
- Copyright, Trademark Suits Netted Big Payouts In 2010
- Experts In Hot Seat In 2010 Product Liability Rulings
- Product Liability Cases To Watch In 2011
- Antitrust Defendants Score Windfall In 2010
- Technology Cases To Watch In 2011
- Fed. Circ. Nixes Deal In Sun Pharma Eloxatin Suit
- Genentech Fights FDA's Downgrade Of Avastin
- SEC Sues InterMune Options Buyers Over Inside Tips
- 3M, Others Urge US To Back High Infringement Standard
- Pfizer Yanks More Lipitor After Odor Problems
- FDA Announces Recall Of Abbott Diabetic Test Strips
- RyMed To Fight Infringement Verdict Over IV Patents
- Ex-UBS Banker Pleads Guilty To Insider Trading Scheme
- Defeating Joinder In Medical Device And Drug Cases
- Sales Reps Hit Daiichi Sankyo With FLSA Action
- Obama Inks $250B Short-Term Funding Bill
- Cleary Gottlieb Reps DSM In $1B Martek Acquisition
- Whistleblower Groups Say SEC Reward Plan Falls Short
- Senate Sends Short-Term Spending Bill To House
- Wyeth Beats W.Va. Fraud Suit Over Hormone Drugs
- Wyeth Loses Bid To Take Novartis IP Suit To Calif.
- Dey To Pay $280M To End Drug Price Inflation Suit
- Bill Seeks Overhaul Of Global Drug Safety Rules
- Cobalt Defense Nixed In Suit Over Generic Boniva
- Czech Energy Cos. Blocked Antitrust Raid, EU Says
- Oracle Drug Software Infringes Patent, Suit Says
- Issa Seeks FDA Probe Into Maker Of Recalled Rolaids
- Bilski Doesn't Doom Prometheus Patents: Fed. Circ.
- Ex-CV Sales Rep Drops Ranexa Marketing Suit
- Pharma Co. Says Insurer Owes It For Reactor Shutdown
- FDA Finds Quality Breaches At J&J Drug Plant
- Mylan Faces Suit Over Orapred ANDA
- Contraceptive Makers Denied Quick End To Patent Suit
- Novo, Sandoz Reach Deal Over Generic Prandin
- Senate Scraps $1.1T Spending Bill
- Bioethics Panel OKs Synthetic Bio, Urges Oversight
- Siemens Partially Off Hook In Lab Test Patent Suit
- PepperBall, Exec Beat $4.8M Securities Fraud Suit
- Medicis Hits Nycomed Unit With 3rd Vanos Patent Suit
- Fen-Phen Atty Deserved Policy Rescission: Insurer
- FTC Urges 11th Circ. To Revive Pay-For-Delay Case
- US Criticizes Planned Parenthood In Overbilling Case
- Generics Cos. Prevail In AstraZeneca's Crestor Suit
- Italy Fines 15 Cos. €81M In Body Care Antitrust Probe
- Case Study: FTC V. Ovation
- Feds Defend 10-Year Sentence For InterMune Exec
- Elan, Eisai To Pay $214M Over Zonegran Marketing
- Respirator Makers Dodge Worker's Asbestos Claims
- FDA Moves To Pull Breast Cancer Approval For Avastin
- Pfizer Wins OK For $75M Deal In Shareholder Suits
- Stryker Sues Zimmer Over Wound System Patent
- FDA Warns Of Hidden Ingredients In Supplements
- In-House Lawyers Attack SEC Whistleblower Program
- A Review Of 2010 Antitrust Class Actions
- Feds Reverse Course, Intervene In Guidant FCA Suit
- Teva's $70M ARS Suit V. Deutsche Tossed For Good
- Covidien Unit Targets Watson Over Generic Exalgo
- Senate Unveils $1.1T Omnibus Spending Bill
- Illumina Suit Over Gene Tech Patents Gets The Boot
- Novartis Finishes Up $51.6B Alcon Purchase
- 3rd Circ. Won't Revive Cephalon Shareholder Case
- FDA Warns Airgas Over Poor Records, Contamination
- J&J Hit With $50M Verdict In Pa. Medicare Suit
- Teva Settles In Bayer Suit Over Generic Yaz
- Ex-Professor Can't Toss St. John's Drug Research Suit
- Matrixx To Pay $15.5M In Zicam MDL
- Purdue Execs Can't Shake Ban From Federal Funds
- Vitamin Maker To Pay FDA $2M Over Health Claims
- Mylan Asks High Court To Review Generics Rulings
- 8th Circ. Shuts Down Medtronic ERISA Action
- Lloyd's Sues To Block Pacific Energy Volcano Claim
- Have Yourself A Merry, Lawsuit-Free Holiday Party
- Galderma Offers $978M For Sweden's Q-Med
- High Court Won't Consider Medical Device Case
- AntiCancer Sues Cellsight Over Tumor Detection IP
- Supreme Court Seeks US Input On Definiteness
- Supreme Court To Rule On Generics Labeling Laws
- MMSEA And Product Liability Claims
- Blue Cross, Others Booted In Pfizer Neurontin MDL
- Japan Orders J&J To Nix Acuvue Price-Display Ban
- Molecular Insight Enters Ch. 11 With $45M Finance Plan
- 2 Accused In Sequenom, EXAS Insider Trading Case
- VNUS Wins $45M Jury Verdict In Medical Laser IP Suit
- Pfizer Used Corruption Info To Pressure Official: Cable
- Supreme Court Weighs Major Shift On Invalidity
- Humana Drops Walgreen Drug Plan Comparisons Suit
- Mental Health: Fair Game In Disability Cases?
- Pfizer Pulls Hypertension Drug Thelin From Market
- Feds Subpoena Medtronic Over Neurostimulator Sales
- J&J Unit Recalls 13M Packages Of Rolaids
- Jenner & Block Adds Ex-Kirkland IP Litigator In LA
- Issa To Head House Oversight Committee
- Whistleblower Suit Over Bone Growth Device Stays Put
- 4th Circ. Affirms UK Jurisdiction In Contract Spat
- J&J Hit With $1.8M Verdict In Levaquin MDL
- 6 Cases Move Forward In Novartis MDL Over Bone Drugs
- Implications Of Genzyme: Loss Under A D&O Policy
- Sales Rep Hits Merck With Overtime Class Action
- EU Fines French Pharmacists €5M For Price-Fixing
- Cravath Reps J&J In $2.3B Bid For Crucell
- Exactech To Pay $3M To Settle Kickbacks Case
- Richards Layton IT Guy Accused Of Insider Trading
- Abbott, Others To Pay $421M Over Drug Price Hikes
- Medicare Stent Scam Cost $3.8M, Senate Report Says
- Cipro Buyers Urge High Court To Rule On Pay-For-Delay
- 9th Circ. Nixes En Banc Bid In Humana Marketing Suit
- Philips' Suit Over Defibrillator Patent Stays Alive
- Reckitt, Watson Drop Patent In Suit Over Mucinex ANDA
- Pfizer Proposes $75M Fund To Settle Shareholder Suits
- Pfizer Wins Verdict In Suit Over Prempro-Cancer Link
- Novatel Marks MiFi Wares With Expired Patents: Suit
- Pharmacy Drops Provigil Class Suit Against Cephalon
- Humana Sues Walgreen Over Drug Cost Comparisons
- Shire Sues Impax, Watson Over Generic Intuniv
- McNeil Asks High Court To Review Drug Failure To Warn
- Judge Tosses Part Of Ex-Wyeth Exec's Firing Suit
- What To Do When Seed Money Gets Personal
- The Best Part Of Waking Up
- EU Antitrust Raids Target AstraZeneca
- Allergan False Marking Case Survives Dismissal Bid
- AstraZeneca Seeks To Halt Mylan's 2nd Seroquel ANDA
- Stryker Loses Bid To Toss Pain Pump Suits
- Momenta, Sandoz Sue Teva Over Lovenox Generic
- Equity Re-Emerges As Strategic M&A Currency: Report
- J&J Recalls Mylanta To Revise Alcohol Labeling
- The Importance Of I4i V. Microsoft
- Univ. Of Wash. Targets GE Over Ultrasound Patent
- Ex-GSK Atty Pleads Not Guilty To FDA Probe Charges
- EU, India Near Settlement In Drug Seizure Row
- 3M, Funai, Others Hit With False Marking Suits
- Novo Patent Fight Over Prandin To Stay In Minn.
- Plaintiffs Exit Bayer MDL But Still Face Discovery
- Ropes & Gray Reps Axcan In $583M Eurand Deal
- The SEC's Lessons For Medical Consultants